|
|
Article: Odyssey Thera granted United States Patent for animal imaging.
- Article from:
- BIOTECH Patent News
- Article date:
- November 1, 2007
CopyrightCOPYRIGHT 2007 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Odyssey Thera, Inc. (San Ramon, CA) announced that the United States Patent and Trademark Office granted United States Patent 7,306,914, entitled "Protein-fragment Complementation Assays in whole animals: applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy." This is the twelfth patent issued for Odyssey Thera's PCA process.
The patent describes a method for detecting protein-protein interactions in living cells and animals. Protein interactions define the intricate biochemical networks in living cells, and are used at Odyssey Thera to monitor drug response. The invention makes it possible to monitor specific ...
Related newspaper, magazine, and journal articles:
|
|
Article: Odyssey Thera Announces a Major Multi-Year ...
PR Newswire;
September 5, 2006 ;
700+ words
... ... Calif., Sept. 5 /PRNewswire/ -- Odyssey Thera, Inc. announced today that it has ... alliance with Pfizer Inc. to utilize Odyssey Thera's Protein-fragment Complementation ... terms of the multi-year agreement, Odyssey Thera will receive an upfront payment, research ...
|
|